Various experiments have evaluated the effect of plk1 knockdown on bladder cancer cells, reporting a reduction in bub1b and an increase in fbxo5 levels as a consequence of plk1 down-regulation. This evidence concerns the gene BUB1B and urinary bladder cancer.